Table 1.
Patients’ characteristics.
| Total | No-PN Group | PN Group | ||
|---|---|---|---|---|
| (n, %) | 443 (100) | 330 (74) | 113 (26) | |
| Female (n, %) | 245 (55) | 183 (56) | 62 (55) | |
| Male (n, %) | 198 (45) | 147 (44) | 51 (45) | |
| Mean Age (SD, years) | 63.6 (12.5) | 64.71 (12.08) | 60.12 (12.96) | |
| Mean BMI (SD) | 23 (5.3) | 24.63 (15.02) | 20.02 (3.36) | |
| <18 (n, %) | 92 (21) | 47 (14) | 45 (40) | |
| 18–25 (n, %) | 228 (51) | 173 (52) | 55 (49) | |
| 25–30 (n, %) | 43 (10) | 37 (12) | 6 (5) | |
| >30 (n, %) | 36 (8) | 34 (10) | 2 (2) | |
| n.d. (n, %) | 44 (10) | 39 (12) | 5 (4) | |
| Mean Creatinine (SD, mg/dL) | 1.1 (0.9) | 1.1 (0.9) | 0.9 (0.7) | |
| Mean Urea (SD, mg/dL) | 24.3 (20) | 25.4 (21.5) | 20.9 (14.1) | |
| Mean Uric Acid (SD, mg/dL) | 6.1 (3.7) | 5.8 (3.6) | 6.2 (3.7) | |
| Tumor Origin (n, %) | ||||
| Gastrointestinal Tumor | 124 (28) | 78 (24) | 46 (41) | |
| HCC 1/CCC 2 | 16 (4) | 11 (3) | 5 (4) | |
| Lung | 85 (19) | 74 (22) | 11 (10) | |
| Breast | 53 (12) | 47 (14) | 6 (5) | |
| ENT 3 | 24 (5) | 17 (5) | 7 (6) | |
| Reproductive organs | 27 (6) | 16 (5) | 11 (10) | |
| RCC 4/Urothelial | 17 (4) | 15 (5) | 2 (2) | |
| Sarcoma | 25 (6) | 18 (6) | 7 (6) | |
| Blood | 23 (5) | 17 (5) | 6 (5) | |
| NET 5 | 7 (1) | 4 (1) | 3 (3) | |
| Brain | 13 (3) | 10 (3) | 3 (3) | |
| Other | 29 (7) | 23 (7) | 6 (5) | |
| Metastasis | Yes | 380 (86) | 280 (85) | 100 (88) |
| No | 63 (14) | 50 (15) | 13 (12) | |
1 Hepatocellular Carcinoma, 2 Cholangiocellular Carcinoma, 3 Ear Nose Throat Tumor, 4 Renal Cell Carcinoma, 5 Neuroendocrine Tumor, SD = Standard Deviation.